Philippe Deecke
Switzerlandbusiness executiveMale6.0Global Dominance: 0.00%Philippe Deecke is the Chief Financial Officer of Lonza, a prominent Swiss pharmaceutical and biotechnology company. Recently, he addressed financial analysts regarding the potential impact of imminent US tariffs on pharmaceuticals, assuring stakeholders that Lonza primarily serves American clients from its US operations and is well-positioned in the biopharmaceutical manufacturing sector.
Power624
Reach7,714
Country presence
Recent news mentions
Philippe Deecke is the CFO of Lonza and commented on the impact of tariffs on generic drug providers.
Lonza wittert in den USA Chancen wegen Zöllen auf GenerikaNeue Zürcher Zeitung·Switzerland· 2026-07-22
Switzerland· 2026-07-22
Philippe Deecke is the CFO of Lonza and expressed concerns about the financial capabilities of pharmaceutical companies.
Lonza investiert künftig lieber anderswo als in der SchweizNeue Zürcher Zeitung·Switzerland· 2026-01-29
Switzerland· 2026-01-29
Philippe Deecke, the CFO of Lonza, addressed financial analysts regarding the company's operations in the US.
US-Zölle bedrohen das Geschäftsmodell der Schweizer PharmabrancheNeue Zürcher Zeitung·Switzerland· 2025-04-12
Switzerland· 2025-04-12
